Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Simple item page
dc.contributor.authorSpencer, Andrew
dc.contributor.authorRoberts, Andrew
dc.contributor.authorKennedy, Nola
dc.contributor.authorRavera, Christina
dc.contributor.authorCremers, Serge
dc.contributor.authorBilic, Sanela
dc.contributor.authorNeeman, Teresa
dc.contributor.authorCopeman, Michael
dc.contributor.authorSchran, Horst
dc.contributor.authorLynch, Kevin
dc.date.accessioned2015-12-10T22:59:18Z
dc.date.issued2007
dc.date.updated2015-12-10T08:11:38Z
dc.identifier.issn0901-9928
dc.identifier.urihttp://hdl.handle.net/1885/61027
dc.publisherBlackwell Publishing Ltd
dc.sourcePharmacology and Toxicology
dc.source.urihttp://www.biomedcentral.com/1472-6904/8/2
dc.titleRenal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study
dc.typeJournal article
local.bibliographicCitation.issue2
local.bibliographicCitation.lastpage4
local.bibliographicCitation.startpage1
local.contributor.affiliationSpencer, Andrew, The Alfred Hospital
local.contributor.affiliationRoberts, Andrew, Royal Melbourne Hospital
local.contributor.affiliationKennedy, Nola, The Alfred Hospital
local.contributor.affiliationRavera, Christina, Novartis Pharmaceuticals Corporation
local.contributor.affiliationCremers, Serge, Novartis Pharmaceuticals Corporation
local.contributor.affiliationBilic, Sanela, Novartis Pharmaceuticals Corporation
local.contributor.affiliationNeeman, Teresa, Administrative Division, ANU
local.contributor.affiliationCopeman, Michael, Novartis Pharmaceuticals Australia
local.contributor.affiliationSchran, Horst, Novartis Pharmaceuticals Corporation
local.contributor.affiliationLynch, Kevin, Novartis Pharmaceuticals Australia
local.contributor.authoruidNeeman, Teresa, u4321232
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110202 - Haematology
local.identifier.ariespublicationu4326120xPUB581
local.identifier.citationvolume8
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Spencer_Renal_safety_of_zoledronic_2007.pdf
Size:
191.03 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS